Bayer Second-Quarter Profit Gains 5.7% Amid Monsanto Pursuit

Updated on
  • German company trims its revenue forecast for this year
  • Crop sciences sales to be flat in “weak market environment”

Bayer AG, the German chemicals company seeking to acquire Monsanto Co., reported a 5.7 percent increase in second-quarter profit as prescription-drug sales helped offset weakness in its crop sciences and consumer health units.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.